CliffBio
small molecule

CUVPOSA

GLYCOPYRROLATE

Loss of exclusivity—loss of exclusivity
CompanyMerz Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameCUVPOSA
Active ingredientGLYCOPYRROLATE
Strength1MG/5ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2010
Marketing statusRX

More from Merz Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CUVPOSA patent cliff — loss of exclusivity — | CliffBio